Avitar, Inc. (OTCMKTS:AVTI)’s stock price fell 25% during mid-day trading on Thursday . The stock traded as low as $0.00 and last traded at $0.00, 4,462,700 shares traded hands during trading. An increase of 305% from the average session volume of 1,102,556 shares. The stock had previously closed at $0.00.
Avitar Company Profile (OTCMKTS:AVTI)
Avitar, Inc is a holding company which through its subsidiaries designs, develops, manufactures, and markets diagnostic test products and proprietary hydrophilic polyurethane foam disposables for medical, diagnostics, dental, and consumer applications in the United States. It offers ORALscreen 4 and ORALscreen DRUGOMETER, the oral fluid-based onsite assay systems, for detecting drugs of abuse, such as opiates, including heroin, morphine, codeine, and synthetic opiates comprising oxycocone-oxycontin, percoset, and hydrocodone-vicodin; cocaine such as crack; marijuana; and methamphetamines, including meth and ecstasy.
Further Reading: Why do earnings reports matter?
Receive News & Ratings for Avitar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avitar and related companies with MarketBeat.com's FREE daily email newsletter.